Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: A retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry

Metastatic Breast Cancer Survival according to HER2 and Topo2a Gene Status

(2013) N. Todorović-Raković et al.   DISEASE MARKERS

Aire's Partners in the Molecular Control of Immunological Tolerance

(2010) Jakub Abramson et al.   CELL

ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction

(2010) J. C. Brase et al.   CLINICAL CANCER RESEARCH

Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer

(2010) Christian Schindlbeck et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Using immunofluorescent digital slide technology to quantify protein expression in archival paraffin-embedded tissue sections

(2010) Akinori Hashiguchi et al.   PATHOLOGY INTERNATIONAL

Early modulation of gene expression used as a biomarker for chemoprevention in a preclinical model of colon carcinogenesis

(2010) Souad Bousserouel et al.   PATHOLOGY INTERNATIONAL

Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy

(2009) Roula Albadine et al.   JOURNAL OF UROLOGY

Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer

(2009) Cathy B Moelans et al.   MODERN PATHOLOGY

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

(2008) Laura Orlando et al.   BREAST

The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells

(2008) David Guay et al.   CANCER SCIENCE

Novel cell death by downregulation of eEF1A1 expression in tetraploids

(2008) Y Kobayashi et al.   CELL DEATH AND DIFFERENTIATION

Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts

(2008) Lydia Usha et al.   Journal of Hematology & Oncology

Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer

(2008) Rui-Xia Guo et al.   PATHOLOGY INTERNATIONAL